97 related articles for article (PubMed ID: 2308599)
1. Thymidylate synthetase gene as a quantitative mutation marker in Chinese hamster cells.
Li IC; Chang CC; Trosko JE
Mutat Res; 1990 Mar; 243(3):233-9. PubMed ID: 2308599
[TBL] [Abstract][Full Text] [Related]
2. Mutants of Chinese hamster cells deficient in thymidylate synthetase.
Li IC; Chu EH
J Cell Physiol; 1984 Aug; 120(2):109-16. PubMed ID: 6611339
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase-deficient Chinese hamster cells: a selection system for human chromosome 18 and experimental system for the study of thymidylate synthase regulation and fragile X expression.
Nussbaum RL; Walmsley RM; Lesko JG; Airhart SD; Ledbetter DH
Am J Hum Genet; 1985 Nov; 37(6):1192-205. PubMed ID: 3002173
[TBL] [Abstract][Full Text] [Related]
4. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
5. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and molecular analyses of ethyl methanesulfonate- and ICR 191-induced mutation in AS52 cells.
Stankowski LF; Tindall KR; Hsie AW
Mutat Res; 1986 Apr; 160(2):133-47. PubMed ID: 3512985
[TBL] [Abstract][Full Text] [Related]
7. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
8. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.
Moran RG; Mulkins M; Heidelberger C
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5924-8. PubMed ID: 160558
[TBL] [Abstract][Full Text] [Related]
9. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells.
Ayusawa D; Koyama H; Seno T
Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line.
Hoganson DK; Williams AW; Berger SH
Biochem Pharmacol; 1999 Nov; 58(10):1529-37. PubMed ID: 10535743
[TBL] [Abstract][Full Text] [Related]
11. Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.
Houghton PJ; Germain GS; Hazelton BJ; Pennington JW; Houghton JA
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1377-81. PubMed ID: 2537495
[TBL] [Abstract][Full Text] [Related]
12. Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthine.
Bogyo D; Mihich E
Cancer Res; 1980 Mar; 40(3):650-4. PubMed ID: 6970615
[TBL] [Abstract][Full Text] [Related]
13. Thymidine 5'-monophosphate-requiring mutants of Saccharomyces cerevisiae are deficient in thymidylate synthetase.
Bisson L; Thorner J
J Bacteriol; 1977 Oct; 132(1):44-50. PubMed ID: 334734
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of methotrexate-induced differentiation of cultured human choriocarcinoma (BeWo) cells by thymidine.
Burres NS; Cass CE
Cancer Res; 1987 Oct; 47(19):5059-64. PubMed ID: 3497716
[TBL] [Abstract][Full Text] [Related]
15. Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis.
Zhao R; Zhang S; Hanscom M; Chattopadhyay S; Goldman ID
Clin Cancer Res; 2005 Feb; 11(3):1294-301. PubMed ID: 15709201
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.
McGuire JJ; Canestrari JG; Nagel GS
Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835
[TBL] [Abstract][Full Text] [Related]
17. Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines.
Browman GP
Cancer Treat Rep; 1982 Dec; 66(12):2051-9. PubMed ID: 6982753
[TBL] [Abstract][Full Text] [Related]
18. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of revertants induced by EMS and u.v. light from a 6-thioguanine resistant HGPRT deficient V79 Chinese hamster cell line.
Hodgkiss RJ; Fox M
Carcinogenesis; 1980 Feb; 1(2):189-98. PubMed ID: 22282999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
